Identification of Novel Circulating miRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia

被引:37
|
作者
Shen, Yi [1 ]
Ding, Yuanjie [1 ]
Ma, Qing [2 ,3 ]
Zhao, Lei [4 ]
Guo, Xudong [1 ]
Shao, Yi [1 ]
Niu, Chen [1 ]
He, Yan [1 ]
Zhang, Feng [1 ]
Zheng, Deqiang [1 ]
Wei, Wenqiang [2 ,3 ]
Liu, Fen [1 ]
机构
[1] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Beijing 100021, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
[4] Univ Iowa, Carver Coll Med, Holden Comprehens Canc Ctr, Dept Mol Physiol & Biophys, Iowa City, IA USA
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
MICRORNA EXPRESSION PROFILE; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; CANCER; SERUM; SIGNATURES; PANEL; PROGRESSION; PROGNOSIS; MIR-92A;
D O I
10.1158/1055-9965.EPI-18-1199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Circulating miRNAs have been identified as diagnostic biomarkers for esophageal squamous cell carcinoma (ESCC), but their efficacy in discovering early-stage ESCC is still unsatisfying. Esophageal squamous dysplasia (ESD) is the precursor lesion of ESCC. Notably, little is known about the role(s) of circulating miRNAs in identifying ESD. In this study, we, therefore, aimed to identify serum miRNAs as novel diagnostic markers for detecting ESD and ESCC. Methods: The genome-wide miRNA expression was profiled in 104 (52 ESCC and 52 controls) serum samples using microarray. Seven candidate miRNAs from the microarray assay were evaluated for their diagnostic performance in another cohort of 266 participants (96 ESCC, 92 ESD, and 78 healthy controls). Results: The serum levels of miR-16-5p, miR-197-5p, miR-451a, and miR-92a-3p were associated with ESCC; the biomarker based on the panel of these four miRNAs could efficiently distinguish patients with ESCC from the controls [AUC = 0.856; 95% confidence interval (CI), 0.794-0.905; P < 0.001]. The serum levels of miR-16-5p, miR-320c, miR-638, and miR-92a-3p were significantly higher in patients with ESD than in controls, and this four-miRNA signature could efficiently differentiate patients with ESD from the controls (AUC = 0.842; 95% CI, 0.778-0.893; P < 0.001). In addition, compared with serum carcinoembryonic antigen and carbohydrate antigen 199, miRNA-based panels had a better diagnostic performance in distinguishing patients with ESCC and ESD from healthy controls. Conclusions: Our study identified two novel panels of circulating miRNAs with high efficiency in detecting ESCC and ESD, suggesting that circulating miRNAs, in particular the combination of them, might serve as noninvasive biomarkers for the early detection of ESCC. Impact: This study suggests the feasibility of using circular miRNA-based blood tests to aid in the detection of ESD and ESCC.
引用
收藏
页码:1212 / 1220
页数:9
相关论文
共 50 条
  • [1] Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
    Ibuki, Yuta
    Nishiyama, Yukie
    Tsutani, Yasuhiro
    Emi, Manabu
    Hamai, Yoichi
    Okada, Morihito
    Tahara, Hidetoshi
    PLOS ONE, 2020, 15 (04):
  • [2] Identification of combinatorial miRNA panels derived from extracellular vesicles as biomarkers for esophageal squamous cell carcinoma
    Wang, Yaojie
    Li, Xiaoya
    Wei, Xiaojian
    Li, Lei
    Bai, Hanyu
    Yan, Xi
    Zhang, Hongtao
    Zhao, Libo
    Zhou, Wei
    Zhao, Lianmei
    MEDCOMM, 2023, 4 (05):
  • [3] Identification of candidate plasma miRNA biomarkers for the diagnosis of head and neck squamous cell carcinoma
    Liu, Weixing
    Liu, Yue
    Li, Pei
    Chen, Jia
    Liu, Jiamin
    Shi, Zhi
    Liu, Hui
    Ye, Jin
    FUTURE SCIENCE OA, 2024, 10 (01):
  • [4] Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update
    Liu, Fen
    Tian, Tian
    Xia, Li-Li
    Ding, Yuanjie
    Cormier, Robert T.
    He, Yan
    DISEASES OF THE ESOPHAGUS, 2017, 30 (02)
  • [5] New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma
    Xu, Shu-Yong
    Liu, Zan
    Ma, Wen-Jing
    Sheyhidin, Ilyar
    Zheng, Shu-Tao
    Lu, Xiao-Mei
    BIOMARKERS, 2009, 14 (05) : 340 - 346
  • [6] Identification of novel biomarkers for lung squamous cell carcinoma
    Guttapadu, Ranjitha
    Katte, Teesta
    Sayeeram, Deepak
    Bhatia, Saloni
    Abraham, Anika Rachel
    Rajeev, Kiran
    Amara, Anish Raju R.
    Siri, Sharadhi
    Bommana, Kavitha
    Rasalkar, Avinash Arvind
    Malempati, Rajyalakshmi
    Mustak, Mohammed S.
    Narayanan, Prathibha
    Reddy, S. Divijendra Natha
    3 BIOTECH, 2023, 13 (02)
  • [7] Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method
    Zhao, Jia
    Fan, Yu-Xia
    Yang, Yang
    Liu, Dong-Lei
    Wu, Kai
    Wen, Feng-Biao
    Zhang, Chun-Yang
    Zhu, Deng-Yan
    Zhao, Song
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (02): : 1535 - 1544
  • [8] Circulating miRNA is a novel marker for head and neck squamous cell carcinoma
    Hsu, Cheng-Ming
    Lin, Pai-Mei
    Wang, Yu-Ming
    Chen, Zong-Jyun
    Lin, Sheng-Fung
    Yang, Ming-Yu
    TUMOR BIOLOGY, 2012, 33 (06) : 1933 - 1942
  • [9] Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis
    Wang, Yanying
    Wang, Qingxiu
    Zhang, Na
    Ma, Hong
    Gu, Yuchun
    Tang, Hongming
    Xu, Zengguang
    Gao, Yong
    TUMOR BIOLOGY, 2014, 35 (11) : 11595 - 11604
  • [10] Serum miRNA expression in patients with esophageal squamous cell carcinoma
    Hui, Beina
    Chen, Xin
    Hui, Lingyun
    Xi, Ruxing
    Zhang, Xiaozhi
    ONCOLOGY LETTERS, 2015, 10 (05) : 3008 - 3012